title: FLT3 Mutation Testing in Acute Myeloid Leukemia.
authors.affiliation: Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas.
authors.forename: Arjun
authors.initials: A
authors.lastname: Gupta
authors.affiliation: Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
authors.forename: David S
authors.initials: DS
authors.lastname: Viswanatha
authors.affiliation: Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
authors.forename: Mrinal M
authors.initials: MM
authors.lastname: Patnaik
mesh_terms: D003561:Cytarabine / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D005820:Genetic Testing / Q000379:methods*; D006261:Headache / Q000209:etiology; D006801:Humans; D007937:Leukapheresis; D015470:Leukemia, Myeloid, Acute / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics; D018921:Leukostasis / Q000175:diagnosis* / Q000235:genetics / Q000628:therapy; D008297:Male; D008875:Middle Aged; D056916:Segmental Duplications, Genomic; D020080:Tandem Repeat Sequences; D014786:Vision Disorders / Q000209:etiology; D051941:fms-Like Tyrosine Kinase 3
chemical_list: D003561:Cytarabine; C497970:FLT3 protein, human; D051941:fms-Like Tyrosine Kinase 3; D003630:Daunorubicin